Oct 31, 2019
November is Alzheimer's Awareness Month-Here Are Four Things to Remember
Jul 14, 2019
Lifestyle Interventions Provide Maximum Memory Benefit When Combined; And May Offset Elevated Alzheimer's Risk Due To Genetics, Pollution
May 16, 2019
Percepta Professional(TM) Nootropic Targeting Brain Plaques and Tangles Featured at 27th Annual Spring Congress on Anti-Aging Medicine
Apr 17, 2019
Neurotrack Awarded $3.3 Million Grant from National Institute on Aging to Study the Impact of its Cognitive Health Digital Therapeutic
Mar 20, 2019
Alliance for Aging Research Releases Survey Results Highlighting Public Interest in Detecting Alzheimer's Disease Early and Participating in Clinical Trials
Feb 12, 2019
Alzheimer's Germ Quest has joined the ACT-AD coalition for accelerating development of Alzheimer's disease therapies, reports Dr. Leslie Norins
Nov 12, 2018
Top scientists at Swiss conference reported promising leads on microbial triggers of Alzheimer's, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest
Nov 08, 2018
Cognitive Clarity Inc. Debuts Percepta® Nootropic at SupplySide West Conference in Las Vegas
Oct 31, 2018
Alzheimer's Foundation of America Statement on Alzheimer's Awareness Month
Oct 18, 2018
United Neuroscience to Present Alzheimer's Vaccine Clinical Trial Update at CTAD 2018
Oct 16, 2018
Infection Specialists at IDWeek Conference Keen to Investigate Microbes as Triggers of Alzheimer's Disease, Says Dr. Leslie Norins
Oct 02, 2018
Alzheimer's "Germ Theory" Gaining Traction, Reports Contagion, newsmagazine on infectious disease
Sep 20, 2018
New Videos Answer Basic Alzheimer's Germ Questions, says Dr. Leslie Norins of Alzheimer's Germ Quest, Inc.
Apr 11, 2018
United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer's Disease
Jan 16, 2018
$1 Million Prize for Alzheimer's Disease Germ Announced by Dr. Leslie Norins on ALZgerm.org
Dec 12, 2017
AXON Meets the First Milestone in an nfvPPA Phase 1 Study With AADvac1
Oct 26, 2017
Brain Health Therapeutics, Developer of Novel Patented Technologies to Improve Outcomes for Alzheimer's Patients, Announces New Team
Jul 25, 2017
MyndYou Collaborates with Mass General Hospital for Research Trial Using MyndYou Platform: